Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N Oxidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for ETP natural product Epicoccin G using photo-oxidation and dimerization. Cost-effective scale-up for pharmaceutical intermediates.
Novel route for dexamethasone using tetraene-pregna-3,20-diketone reduces steps and cost for pharmaceutical intermediate manufacturing.
Novel synthesis of Roxadustat via Bischler-Napieralski cyclization offers high purity and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN120484042B reveals a 5-step HE3286 synthesis route offering significant cost reduction in pharmaceutical manufacturing and high-purity API intermediate supply chain reliability.
Patent CN101805389A details a novel 3-step semi-synthetic route for Corosolic Acid from Ursolic Acid, offering >98% purity and significant cost reduction for pharmaceutical manufacturing.
Advanced synthesis of 5-oxo-tetrahydropyran-3-carboxylic ester via Pd-catalyzed carbonylation. Offers cost reduction in API manufacturing and scalable production.
Patent CN115850252A discloses a novel iron-iodine co-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN111393427A reveals a safer, high-yield synthesis for pyroxasulfone intermediates, offering significant cost reduction and supply chain reliability for global herbicide manufacturers.
Patent CN104910079B reveals efficient one-pot oxidation for 4(3H)-quinazolinone derivatives. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel one-pot method for Imatinib intermediate reduces toxicity and improves yield for pharmaceutical manufacturing supply chains.
Patent CN1241914C details an efficient method for 7-quinolinyl-3,5-dihydroxyhept-6-enoate, offering superior purity and scalable production for HMG-CoA inhibitor manufacturing.
Patent CN107011133B reveals a green nitrite-catalyzed method for oxidizing benzylic C-H bonds to ketones, offering cost reduction in API manufacturing without metal residues.
Patent CN103930410B reveals iron-catalyzed epoxidation for high-purity DVBDO. Achieve cost reduction in epoxy resin manufacturing with scalable methods.
Novel dehydration-epoxidation route for Delta9,11-canrenone achieves >80% yield. Reduces steps vs fermentation. Ideal for eplerenone manufacturing.
Patent CN108659043B details a cost-effective CAN-catalyzed route for E-alkenyl diphenylphosphines, offering superior atom economy and simplified purification for pharmaceutical intermediates.
Novel non-toxic route for 2-(3-cyano-4-isobutoxy phenyl)-4-methyl-thiazole-5-carboxylic acid avoiding cyanides and corrosive acids.
Novel 4-step synthesis of antiviral intermediate Phthiobuzone reduces bromine usage and improves scalability for reliable pharmaceutical supply chains.
Novel manganese-catalyzed process for carfilzomib intermediates significantly reduces cost and waste. Reliable pharmaceutical intermediate supplier for global scale manufacturing.
Patent CN106854200B reveals high-purity Ceritinib synthesis. Optimized catalytic route ensures supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN113512569B details a green enzymatic route for Lopinavir intermediates. Achieve high purity and cost reduction in API manufacturing with our advanced biocatalytic solutions.